315 related articles for article (PubMed ID: 34712616)
1. [
Valtorta S; Toscani D; Chiu M; Sartori A; Coliva A; Brevi A; Taurino G; Grioni M; Ruffini L; Vacondio F; Zanardi F; Bellone M; Moresco RM; Bussolati O; Giuliani N
Front Oncol; 2021; 11():760732. PubMed ID: 34712616
[TBL] [Abstract][Full Text] [Related]
2. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
Front Immunol; 2022; 13():821423. PubMed ID: 35145523
[TBL] [Abstract][Full Text] [Related]
3. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
[TBL] [Abstract][Full Text] [Related]
5. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
[TBL] [Abstract][Full Text] [Related]
6. (2S,4R)-4-[
Zhu H; Liu F; Zhang Y; Yang J; Xu X; Guo X; Liu T; Li N; Zhu L; Kung HF; Yang Z
Mol Imaging Biol; 2019 Oct; 21(5):945-953. PubMed ID: 30793240
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging of
Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
[TBL] [Abstract][Full Text] [Related]
9. (2S, 4R)-4-[
Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
[TBL] [Abstract][Full Text] [Related]
10. Alanine and glycine conjugates of (2S,4R)-4-[
Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF
Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446
[TBL] [Abstract][Full Text] [Related]
11. Comparison of: (2
Miner MWG; Liljenbäck H; Virta J; Helin S; Eskola O; Elo P; Teuho J; Seppälä K; Oikonen V; Yang G; Kindler-Röhrborn A; Minn H; Li XG; Roivainen A
Front Oncol; 2021; 11():730358. PubMed ID: 34692505
[TBL] [Abstract][Full Text] [Related]
12. Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.
Jeitner TM; Kristoferson E; Azcona JA; Pinto JT; Stalnecker C; Erickson JW; Kung HF; Li J; Ploessl K; Cooper AJL
J Fluor Chem; 2016 Dec; 192(A):58-67. PubMed ID: 28546645
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
[TBL] [Abstract][Full Text] [Related]
14. Dynamic PET/CT imaging of
Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Xie Q; Zhu L; Li N; Kung HF; Yang Z
Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2280-2292. PubMed ID: 32166510
[TBL] [Abstract][Full Text] [Related]
15. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
[TBL] [Abstract][Full Text] [Related]
16. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
Cooper AJ; Krasnikov BF; Pinto JT; Kung HF; Li J; Ploessl K
Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):108-20. PubMed ID: 22613816
[TBL] [Abstract][Full Text] [Related]
17. KRAS Mutation Detection with (2
Liu S; Liu F; Hou X; Zhang Q; Ren Y; Zhu H; Yang Z; Xu X
Mol Pharm; 2024 Apr; 21(4):2034-2042. PubMed ID: 38456403
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of (2S,4S)-4-[
Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
[TBL] [Abstract][Full Text] [Related]
19. Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module.
Zhang X; Basuli F; Shi ZD; Xu B; Blackman B; Choyke PL; Swenson RE
Appl Radiat Isot; 2016 Jun; 112():110-4. PubMed ID: 27019029
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
